Advertisement
Screener

ACRO BIOMEDICAL CO., LTD. (ACBM) Increase (Decrease) in Deferred Income Taxes

2.8 / 5 stars · 68/120 Roast Me

ACRO BIOMEDICAL CO., LTD. Increase (Decrease) in Deferred Income Taxes

ACRO BIOMEDICAL CO., LTD. (ACBM) reported Increase (Decrease) in Deferred Income Taxes of -$19.94 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-04-02.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2021-04-02

  • ACRO BIOMEDICAL CO., LTD. increase (decrease) in deferred income taxes for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
  • ACRO BIOMEDICAL CO., LTD. increase (decrease) in deferred income taxes for the quarter ending 2019-09-30 was -$9.87K.
  • ACRO BIOMEDICAL CO., LTD. increase (decrease) in deferred income taxes for the quarter ending 2019-06-30 was -$55.19K.
  • ACRO BIOMEDICAL CO., LTD. increase (decrease) in deferred income taxes for the quarter ending 2019-03-31 was $45.12K.
  • ACRO BIOMEDICAL CO., LTD. increase (decrease) in deferred income taxes for fiscal 2019 was -$19.94K.
Period endIncrease (Decrease) in Deferred Income Taxes 3 monthIncrease (Decrease) in Deferred Income Taxes 6 monthIncrease (Decrease) in Deferred Income Taxes 9 monthIncrease (Decrease) in Deferred Income Taxes 12 month
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-02
-$9.87K
derived: sum of 2 quarters · filed 2021-04-02
-$65.06K
derived: sum of 3 quarters · filed 2021-04-02
-$19.94K
10-K · filed 2021-04-02
2019-09-30-$9.87K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-17
-$65.06K
derived: sum of 2 quarters · filed 2020-11-17
-$19.94K
10-Q · filed 2020-11-17
$0.00
derived: sum of 4 quarters · filed 2021-04-02
2019-06-30-$55.19K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-19
-$10.07K
10-Q · filed 2020-08-19
$9.87K
derived: sum of 3 quarters · filed 2021-04-02
2019-03-31$45.12K
10-Q · filed 2020-05-19
$65.06K
derived: sum of 2 quarters · filed 2021-04-02
2018-12-31$19.94K
10-K · filed 2021-04-02